Transcatheter occlusion of the patent ductus arteriosus in premature infants weighing less than 1200 g.
Morville, Patrice; Douchin, Stephanie; Bouvaist, Helene; Dauphin, Claire.
Arch Dis Child Fetal Neonatal Ed
; 103(3): F198-F201, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29066474
Percutaneous Ventricular Septal Defect Closure in Patients Under 1 Year of Age.
Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Predictive Factors for Patients Undergoing ASD Device Occlusion Who "Crossover" to Surgery.
Corrected balloon occlusive diameter to determine device size during percutaneous atrial septal defect closure.
Transcatheter Closure of Atrial Septal Defects: Comparable Experience and Outcomes Between Developing and Developed Countries.
Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
Percutaneous removal of unraveled HELEX® septal occluder 4 months post deployment.
Safety of transcatheter patent ductus arteriosus closure in small weight infants.
Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.
Techniques for transcatheter retrieval of the occlutech ASD device United Kingdom-European multicenter report.